Global Drug-eluting Microsphere Market Growth 2025-2031

The global Drug-eluting Microsphere market size is predicted to grow from US$ 855 million in 2025 to US$ 2091 million in 2031; it is expected to grow at a CAGR of 16.1% from 2025 to 2031.

Drug-eluting Microsphere, delivered by transarterial chemoembolization (TACE) serve as a therapeutic embolic to stop blood flow to tumors and a drug delivery vehicle.

United States market for Drug-eluting Microsphere is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Drug-eluting Microsphere is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Drug-eluting Microsphere is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Drug-eluting Microsphere players cover Boston Scientific, Merit Medical, Terumo, Suzhou Hengrui Medical, Varian, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Drug-eluting Microsphere Industry Forecast” looks at past sales and reviews total world Drug-eluting Microsphere sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug-eluting Microsphere sales for 2025 through 2031. With Drug-eluting Microsphere sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-eluting Microsphere industry.

This Insight Report provides a comprehensive analysis of the global Drug-eluting Microsphere landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-eluting Microsphere portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug-eluting Microsphere market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-eluting Microsphere and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-eluting Microsphere.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug-eluting Microsphere market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
70～150μm
100～300μm
300～500μm
Other

Segmentation by Application:
Transcatheter Hepatic Arterial Chemoembolization
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Boston Scientific
Merit Medical
Terumo
Suzhou Hengrui Medical
Varian
Cardiolink Science

Key Questions Addressed in this Report

What is the 10-year outlook for the global Drug-eluting Microsphere market?

What factors are driving Drug-eluting Microsphere market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Drug-eluting Microsphere market opportunities vary by end market size?

How does Drug-eluting Microsphere break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more